Invention Title:

DIGITAL FERROFLUIDIC DEVICE AND METHOD FOR MULTIPLEXED ASSAYS AND VIRAL TESTING

Publication number:

US20260335895

Publication date:
Section:

Performing operations; transporting

Class:

B01L3/502784

Inventors:

Assignee:

Applicant:

Smart overview of the Invention

The digital ferrofluidic device is designed for multiplexed assays and viral testing, utilizing a swarm of millimeter-sized magnets, known as "ferrobots," to handle magnetized sample droplets accurately. This device operates on a palm-sized programmable platform, allowing for various bioanalytical operations involved in pooled testing. It has been successfully applied to detect the SARS-COV-2 virus in clinical samples, providing results that match traditional off-chip methods. The technology promises significant reductions in both reagent and instrumentation costs, making it a cost-effective solution for large-scale viral testing.

Technical Field

This technology falls under the category of digital fluidic platforms, specifically those that use electronic actuation of individual coils on a substrate to generate magnetic fields. These fields control moveable permanent magnets, which in turn manipulate magnetic droplets. The platform supports automated, multiplexed assays and can be employed for pooled clinical sample testing, including viral detection.

Background

The frequent emergence of epidemics and pandemics, such as COVID-19, highlights the need for robust viral diagnostic and surveillance testing. Nucleic acid amplification tests (NAATs) are preferred for their sensitivity and specificity, but existing platforms are often expensive and inefficient. The need for accessible, automated testing platforms that can handle high throughput, fast turnaround times, and minimal resource use is critical. Current systems are limited by their size, cost, and resource requirements, restricting them to centralized labs.

Summary of Innovation

The introduced platform enables adaptive pooled testing through programmable liquid handling and bioanalytical operations, using ferrobots to manipulate ferro-droplets with precision. This integration of fluidware, hardware, and software supports versatile NAAT-centered workflows, such as RT-LAMP. A prevalence-based adaptive testing algorithm optimizes testing modes, maximizing screening efficiency without complex sample handling. This approach offers substantial resource savings compared to traditional individual testing methods.

Device and Method Embodiments

One embodiment features a ferrofluidic assay device with substrates containing addressable coils and movable permanent magnets. These components manipulate ferrofluid volumes for various operations, such as mixing and pooling samples. Another embodiment describes a portable device using microfluidic chips to capture and enrich target species, like nucleic acids, from samples. This enriched material is delivered to assay chambers for optical interrogation, identifying the presence or abundance of target species.